Home » FDA Piloting Risk-Benefit Decisionmaking Framework
FDA Piloting Risk-Benefit Decisionmaking Framework
The FDA is using a decisionmaking matrix to weigh expected clinical benefits for biopharmaceuticals against their risks in a pilot program using six NME applications under review.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
07May
-
14May
-
30May